Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Investors Push for Charles River Labs Sale

By Pharmaceutical Processing | December 9, 2010

NEW YORK (AP) — One of the largest investors in Charles River Laboratories
International Inc. has taken a bigger stake in the company, and according to
media reports, it is pushing the medical research company to sell itself.

Relational Investors LLC disclosed Wednesday that it now owns about 3.2
million shares of Charles River Labs, or 5.6 percent of the company. That’s up
from around 2.6 million shares, or 4.5 percent of the company. The Wall Street
Journal reported Thursday that Relational is pushing management to sell the
company, and added that the California teacher’s pension fund also bought more
shares and has joined the push for a sale.

It said the California State Teachers’ Retirement System and Relational own a
combined 6.1 percent of Charles River Labs.

Charles River Labs provides medical research equipment and services to drug
companies and other customers. Relational is the third-largest shareholder in
the company, and it was one of the firms that criticized Charles River Labs
management earlier this year over plans to pay $1.6 billion to buy WuXi
PharmaTech Inc., a pharmaceutical outsourcing company
based in China. The deal broke up after following opposition from Charles River
Labs shareholders.

Charles River Labs, based in Wilmington, Mass., did not immediately respond
to requests for comment. Company shares rose slightly in aftermarket trading.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE